Operating Income
ResMed Operating Income increased by 1.7% to $499.81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $426.27M to $499.81M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 16.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Detailed definition
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
Peer comparison
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
operating_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $241.64M | $261.91M | $248.71M | $234.27M | $255.40M | $275.74M | $280.19M | $300.67M | $275.27M | $289.00M | $275.09M | $374.58M | $381.22M | $387.31M | $417.24M | $426.27M | $454.54M | $446.54M | $491.66M | $499.81M |
| QoQ Change | — | +8.4% | -5.0% | -5.8% | +9.0% | +8.0% | +1.6% | +7.3% | -8.4% | +5.0% | -4.8% | +36.2% | +1.8% | +1.6% | +7.7% | +2.2% | +6.6% | -1.8% | +10.1% | +1.7% |
| YoY Change | — | — | — | — | +5.7% | +5.3% | +12.7% | +28.3% | +7.8% | +4.8% | -1.8% | +24.6% | +38.5% | +34.0% | +51.7% | +13.8% | +19.2% | +15.3% | +17.8% | +17.3% |
Business Segments — Sleep and Respiratory Care
| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Respiratory Care | $352.56M | $373.37M | $390.70M | $330.50M | $390.42M | $426.39M | $456.18M | $408.36M |
| Total | $275.74M | $280.19M | $300.67M | $275.27M | $289.00M | $275.09M | $374.58M | $381.22M |
Software as a Service is derived from annual filings.
Sleep and Respiratory Care, Software as a Service, Software As Service, Total Sleep and Respiratory Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Sleep And Breathing Health
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Sleep And Breathing Health | $460.98M | $488.72M | $494.80M | $519.89M | $530.62M | $571.85M | $575.41M |
| Residential Care Software | $47.62M | $48.88M | $53.18M | $55.32M | $54.02M | $50.05M | $58.24M |
| Total | $387.31M | $417.24M | $426.27M | $454.54M | $446.54M | $491.66M | $499.81M |
Operating Income at Other Companies
Frequently Asked Questions
- What is ResMed's operating income?
- ResMed (RMD) reported operating income of $499.81M in Q1 2026.
- How has ResMed's operating income changed year-over-year?
- ResMed's operating income increased by 17.3% year-over-year, from $426.27M to $499.81M.
- What is the long-term trend for ResMed's operating income?
- Over 4 years (2021 to 2025), ResMed's operating income has grown at a 16.9% compound annual growth rate (CAGR), from $903.68M to $1.69B.
- What does operating income mean?
- The profit a company makes from its core business operations before interest and taxes.